In EUCanScreen, the work on risk-based approaches to screening includes much quantitative work, for example determining risk-thresholds, and qualitative methodologies, which are an essential part to understand the perceptions, opportunities, and challenges of risk-based screening. We are using one qualitative method, focus group discussion, in two different ways, across two tasks (T9.1 & T9.6). Both of these methods, their associated research questions, aim and implementation are described below. We hope highlighting these approaches sheds light on the importance of integrating qualitative methods into quantitative approaches, to make them richer and more impactful.
Focus group discussions on integrating prevention with cancer screening (EUCanScreen Task 9.6)
The focus groups address three linked questions.
First, what are the strengths, weaknesses, opportunities and threats (SWOT) of current approaches to linking primary, secondary and tertiary prevention with cancer screening in Europe?
Second, what conditions (organisational, data-related, behavioural and social, financial, etc.) allow or prevent screening programmes from serving as an entry point to wider prevention, such as risk-factor counselling, referral to lifestyle interventions or follow-up care?
Third, how could data infrastructures, in particular the European Health Data Space (EHDS) support this integration in practice?
The focus groups build on a scoping review that mapped ongoing prevention and screening initiatives in Europe aligned with Europe’s Beating Cancer Plan. The review identified promising practices and open questions, which shaped the discussion guide. We are currently conducting online focus groups with practitioners and stakeholders involved in prevention strategies, including screening programme managers, primary care and public health professionals, data and surveillance experts, policymakers and patient or civil-society representatives from 29 countries. We have completed 3 of 6 focus group discussions. Discussions follow a structured SWOT format. They are recorded, transcribed and analysed thematically.
The results will feed directly into the Task 9.6 roadmap on best practices for integrating prevention with screening and will combine the focus group results with findings from the other WP9 tasks on risk-based screening. The SWOT results will identify priority actions, enabling conditions and risks that Member States need to address should they want to strengthen risk-based screening.
Focus group discussions on perceptions, opinions and acceptability of risk-stratified screenings by citizens and healthcare professionals (EUCanScreen Task 9.1)
The focus groups address these linked questions.
For citizens
For healthcare professionals
We have drafted the protocol and the focus group discussion guides – one for each cancer type: breast, cervical, colorectal, prostate and lung – for submission by each participating centre to its respective ethics committee in Italy, Ireland, Latvia, Slovenia and Spain.
We are preparing the participant information material explaining what risk-stratified screening is, for each cancer type. The material will be based on the consensus-based conceptual framework on risk-stratified screening (Giorgi Rossi P, Senore C, Giordano L, et al. Risk-stratified cancer screening: A consensus-based conceptual framework from EUCanScreen. Eur J Cancer. 2026 Jun 3;240:116746) and related materials.
The results will help to fill the knowledge gap on the acceptability of, and information needs about, risk-based screening among citizens and health professionals, and will inform the development of best practices for communication in risk-based screening (Deliverable 9.1).
For more information on these methods please contact and .
Gabrielle Schittecatte, Epidemiology and Public Unit, Cancer Centre, Sciensano, Belgium
Cinzia Colombo, Unit Research with citizens for the prevention and cure of diseases, IRFMN, Istituto Mario Negri, Milan, Italy
Béatrice Fervers, Département Prévention Cancer Environnement, Centre Léon Bérard – Centre de Prévention, Lyon, France
Tala Haddad, Unicancer, Paris, France
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor HaDEA can be held responsible for them.
This website is managed by 6th DYPEDE, Greece.